[HTML][HTML] Pemphigus: current and future therapeutic strategies

D Didona, R Maglie, R Eming, M Hertl - Frontiers in immunology, 2019 - frontiersin.org
Pemphigus encompasses a heterogeneous group of autoimmune blistering diseases, which
affect both mucous membranes and the skin. The disease usually runs a chronic-relapsing …

Integrating cell-signalling pathways with NF-κB and IKK function

ND Perkins - Nature reviews Molecular cell biology, 2007 - nature.com
Nuclear factor (NF)-κB and inhibitor of NF-κB kinase (IKK) proteins regulate many
physiological processes, including the innate-and adaptive-immune responses, cell death …

International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma

KF Chung, SE Wenzel, JL Brozek… - European respiratory …, 2014 - Eur Respiratory Soc
Severe or therapy-resistant asthma is increasingly recognised as a major unmet need. A
Task Force, supported by the European Respiratory Society and American Thoracic Society …

European position paper on rhinosinusitis and nasal polyps 2012

WJ Fokkens, VI Lund, J Mullol, C Bachert, I Alobid… - Rhinology, 2012 - biblio.ugent.be
The methodology for EPOS2012 has been the same as for the other two productions.
Leaders in the field were invited to critically appraise the literature and write a report on a …

Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma

J Bousquet, E Mantzouranis, AA Cruz… - Journal of Allergy and …, 2010 - Elsevier
Asthma is a global health problem affecting around 300 million individuals of all ages, ethnic
groups and countries. It is estimated that around 250,000 people die prematurely each year …

[HTML][HTML] New insights into the pathophysiology and therapeutic targets of asthma and comorbid chronic rhinosinusitis with or without nasal polyposis

I Striz, K Golebski, Z Strizova, S Loukides… - Clinical …, 2023 - portlandpress.com
Asthma and chronic rhinosinusitis with nasal polyps (CRSwNP) or without (CRSsNP) are
chronic respiratory diseases. These two disorders often co-exist based on common …

Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction

KF Chung, IM Adcock - European Respiratory Journal, 2008 - Eur Respiratory Soc
Chronic obstructive pulmonary disease is a leading global cause of morbidity and mortality
that is characterised by inexorable deterioration of small airways obstruction with …

MicroRNA-21 drives severe, steroid-insensitive experimental asthma by amplifying phosphoinositide 3-kinase–mediated suppression of histone deacetylase 2

RY Kim, JC Horvat, JW Pinkerton, MR Starkey… - Journal of Allergy and …, 2017 - Elsevier
Background Severe steroid-insensitive asthma is a substantial clinical problem. Effective
treatments are urgently required, however, their development is hampered by a lack of …

Current and emerging drugs for the treatment of inflammatory bowel disease

JK Triantafillidis, E Merikas… - … design, development and …, 2011 - Taylor & Francis
During the last decade a large number of biological agents against tumor necrosis factor-α
(TNF-α), as well as many biochemical substances and molecules specifically for the medical …

[HTML][HTML] Selective glucocorticoid receptor modulation: New directions with non-steroidal scaffolds

N Sundahl, J Bridelance, C Libert… - Pharmacology & …, 2015 - Elsevier
Glucocorticoids remain the frontline treatment for inflammatory disorders, yet represent a
double-edged sword with beneficial therapeutic actions alongside adverse effects, mainly in …